Protocol of the Swiss Longitudinal Cohort Study (SWICOS) in rural Switzerland

Andreas W Schoenenberger, Franco Muggli, Gianfranco Parati, Augusto Gallino, Georg Ehret, Paolo M Suter, Renate Schoenenberger-Berzins, Therese J Resink, Paul Erne, Andreas W Schoenenberger, Franco Muggli, Gianfranco Parati, Augusto Gallino, Georg Ehret, Paolo M Suter, Renate Schoenenberger-Berzins, Therese J Resink, Paul Erne

Abstract

Introduction: Increased longevity and consequent major changes in demographics and population lifestyles necessitate new approaches to reduce the burden of ageing-related diseases (including cardiovascular disease) and maintain an optimal quality of life. This study aims to examine and longitudinally follow health status and disease risk factors in a Swiss rural cohort, evaluating all health-related research and practice disciplines to assure development of new implementable and successful preventive strategies for healthy ageing.

Methods and objectives: Small Swiss villages with low migration rates will be selected for this study. 2 villages (Cama/Lostallo) have already been selected as initial study sites. All residents (age ≥6 years, no upper age limit) are eligible. The target enrolment number per village is 300. Examinations and measurements encompass medical history, anthropometry, cardiac and vascular health, pulmonary function, physical performance, nutritional, mental and emotional status, biochemical and molecular analyses. Follow-up examinations (identical to baseline) will be performed after 5 and 10 years, and in 10-year intervals thereafter. The major objective is to assess, and observe change in, health status over time in a prospective manner. Secondary objectives are to: (1) identify 'hidden' (asymptomatic and/or unrecognised) health problems which enhance risk for chronic diseases; (2) identify barriers to accessing healthcare and adapting health behaviours; (3) evaluate efficacy of present preventive strategies and recommendations; (4) evaluate knowledge and attitude towards ongoing health programmes and public health recommendations; (5) monitor change and progress towards the national health objectives; (6) formulate new preventive strategies and recommendations based on the findings and knowledge base of the past 10 years; (7) formulate models for successful prevention of chronic diseases and for healthy ageing.

Ethics and dissemination: The Ethics Committee of Nordwest-und Zentralschweiz approved this study (EKNZ 2014-209). It is registered at ClinicalTrials.gov (NCT02282748). Findings will be disseminated through scientific articles/presentations and public events.

Keywords: eipdemiology; health status; prevention; risk factors.

Conflict of interest statement

FM and PE are advisors to TensioMed GmbH (Switzerland). PE served as advisor to Inovise Medical (USA), the manufacturer of the Audicor device.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

References

    1. Swiss Federal Statistical Office: Components of population change—Data, indicators_Life expectancy. .
    1. Brindle P, Beswick A, Fahey T et al. . Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006;92:1752–9. 10.1136/hrt.2006.087932
    1. Grundy SM, Balady GJ, Criqui MH et al. . Guide to primary prevention of cardiovascular diseases—a statement for healthcare professionals from the task force on risk reduction. Circulation 1997;95:2329–31.
    1. Pearson TA, Blair SN, Daniels SR et al. . AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update—consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002;106:388–91.
    1. Pearson TA, Palaniappan LP, Artinian NT et al. . American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation 2013;127:1730–53. 10.1161/CIR.0b013e31828f8a94
    1. Todesursachenstatistik. Sterblichkeit und deren Hauptursachen in der Schweiz.
    1. D'Agostino RB, Vasan RS, Pencina MJ et al. . General cardiovascular risk profile for use in primary care—the Framingham Heart Study. Circulation 2008;117:743–53. 10.1161/CIRCULATIONAHA.107.699579
    1. Hubert HB, Feinleib M, Mcnamara PM et al. . Obesity as an independent risk factor for cardiovascular-disease—a 26-year follow-up of participants in the Framingham Heart-Study. Circulation 1983;67:968–77.
    1. Kannel WB, Feinleib M, Mcnamara PM et al. . Investigation of coronary heart-disease in families—Framingham offspring study. Am J Epidemiol 1979;110:281–90.
    1. Sytkowski PA, Kannel WB, Dagostino RB. Changes in risk-factors and the decline in mortality from cardiovascular-disease. The Framingham Heart-Study. N Engl J Med 1990;322:1635–41. 10.1056/NEJM199006073222304
    1. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998;19(Suppl A):A2–A11.
    1. Cullen P, Schulte H, Assmann G. The Munster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers. Circulation 1997;96:2128–36.
    1. Swiss Atherosclerosis Association (Arbeitsgruppe Lipide und Atherosklerose (AGLA) der Schweizerischen Gesellschaft für Kardiologie). .
    1. The Baltimore Longitudinal Study of Aging (BLSA). .
    1. De Pietro C, Camenzind P, Sturny I et al. . Switzerland: health system review. Health Syst Transit 2015;17:1–288.
    1. Federal Office of Public Health FOPH: A comprehensive health care strategy. .
    1. Widmer LK, Greenshe A, Kannel WB. Occlusion of peripheral arteries—study of 6400 working subjects. Circulation 1964;30:836–52.
    1. Swiss cohort study on air pollution.
    1. Guessous I, Bochud M, Theler JM et al. . 1999–2009 Trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PLoS ONE 2012;7:e39877 10.1371/journal.pone.0039877
    1. The CoLaus (Cohorte Lausannoise) study. .
    1. The Swiss Kidney Project on Genes in Hypertension (SKIPOGH). .
    1. Burnier M, Wuerzner G, Bochud M. Salt, blood pressure and cardiovascular risk: what is the most adequate preventive strategy? A Swiss perspective. Front Physiol 2015;6:227 10.3389/fphys.2015.00227
    1. Nationales Programm Ernährung und Bewegung (NPEB).
    1. SAPALDIA Cohort on Healthy Aging. .
    1. Ogden CL, Carroll MD, Kit BK et al. . Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA 2012;307:483–90.
    1. Suter PM, Ruckstuhl N. Obesity during growth in Switzerland: role of early socio-cultural factors favouring sedentary activities. Int J Obes 2006;30:S4–S10.
    1. Bundesamt für Gesundheit (BAG). Gesundheit2020. Die gesundheitspolitischen Prioritäten des Bundesrates.
    1. Protection of personal data—European Commission.
    1. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007;165:710–18. 10.1093/aje/kwk052
    1. Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics 1983;39:499–503.
    1. Topouchian J, Agnoletti D, Blacher J et al. . Validation of four devices: Omron M6 Comfort, Omron HEM-7420, Withings BP-800, and Polygreen KP-7670 for home blood pressure measurement according to the European Society of Hypertension International Protocol. Vasc Health Risk Manag 2014;10:33–44. 10.2147/VHRM.S53968
    1. Horvath IG, Nemeth A, Lenkey Z et al. . Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 2010;28:2068–75. 10.1097/HJH.0b013e32833c8a1a
    1. Benetti E, Fania C, Marquez Hernandez V et al. . Validation of the Thermor BIOS BD215 device for home blood pressure measurement according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit 2014;19:176–9. 10.1097/MBP.0000000000000030
    1. Yip GW, So HK, Li AM et al. . Validation of A&D TM-2430 upper-arm blood pressure monitor for ambulatory blood pressure monitoring in children and adolescents, according to the British Hypertension Society protocol. Blood Press Monit 2012;17:76–9. 10.1097/MBP.0b013e328351d4a4
    1. Caravita S, Faini A, Bilo G et al. . Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand. Int J Cardiol 2014;171:e100–2. 10.1016/j.ijcard.2013.12.003
    1. Erne P. Beyond auscultation—acoustic cardiography in the diagnosis and assessment of cardiac disease. Swiss Med Wkly 2008;138:439–52.
    1. Kobza R, Roos M, Toggweiler S et al. . Recorded heart sounds for identification of ventricular tachycardia. Resuscitation 2008;79:265–72. 10.1016/j.resuscitation.2008.05.013
    1. Henkin P, Priest RS, Schiller G. Compendium of ophthalmology. Philadelphia: J.P. Lippincott Company, 1983.
    1. Macphee GJ, Crowther JA, McAlpine CH. A simple screening test for hearing impairment in elderly patients. Age Ageing 1988;17:347–51
    1. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98.
    1. Shulman KI, Shedlestky R, Silver I. The challenge of time: clock drawing and cognitive function in the elderly. Int J Geriatr Psychiatry 1986;1:135–40.
    1. Tombaugh TN. Trail making test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 2004;19:203–14. 10.1016/S0887-6177(03)00039-8
    1. Degryse J, Buffels J, Van Dijck Y et al. . Accuracy of office spirometry performed by trained primary-care physicians using the MIR Spirobank hand-held spirometer. Respiration 2012;83:543–52.
    1. Rossier P, Wade DT. Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment. Arch Phys Med Rehabil 2001;82:9–13.
    1. Fess EE. Grip strength. In: Casanova JS, ed. Clinical assessment recommendations. Chicago: American Society of Hand Therapists, 1992:41–5.
    1. Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport 1999;70:113–19.
    1. Centers for Disease Control and Prevention. .
    1. Katz S, Ford AB, Moskowitz RW et al. . Studies of illness in the aged. The Index of Adl: a standardized measure of biological and psychosocial function. JAMA 1963;185:914–19.
    1. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–86.
    1. Kroenke K, Spitzer RL, Williams JB et al. . The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 2010;32:345–59.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir